BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27

• Press Releases

  Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026

  July 24, 2026

   · 

  3 min read
• Press Releases

  MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

  July 24, 2026

   · 

  7 min read
• Press Releases

  Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

  July 24, 2026

   · 

  1 min read
• Press Releases

  Cytokinetics to Announce Second Quarter Results on August 6, 2026

  July 24, 2026

   · 

  3 min read
• Press Releases

  Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

  July 24, 2026

   · 

  11 min read
• Press Releases

  Icahn Enterprises L.P. Announces Q2 2026 Earnings Conference Call

  July 24, 2026

   · 

  1 min read
• Press Releases

  Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering

  July 24, 2026

   · 

  4 min read
• Press Releases

  Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth

  July 24, 2026

   · 

  10 min read
• Press Releases

  Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

  July 24, 2026

   · 

  5 min read
• Press Releases

  Codexis Announces Pricing of Public Offering of Common Stock - July 23, 2026

  July 24, 2026

   · 

  3 min read